Jacques Attali Appointed to the Board of Directors at the Biopharma Start-up Company Pharnext

PARIS, Santé Cochin business incubator, December 4, 2007 – Pharnext, a biopharmaceutical company specializing in the development of innovative treatments for severe neurological diseases, has today announced the appointment of Jacques Attali to its Board of Directors.